Early achievement of optimal medical therapy and its impact on survival and morbidity: results from a nationwide implementation science study (BRING-UP-3 HF)

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Francesco Orso

ANMCO Research Center, Florence (Italy)

4 More presentations in this session

Presentation thumbnail

Phenotyping the cardiomyopathy spectrum: large-scale analysis of clinical and comorbidity status in the prospective TORCH cohort

Doctor C. Reich (Heidelberg, DE)

Abstract Slides Video

Presentation thumbnail

Ten-year real-world incidence and prognostic impact of new-onset heart failure after acute coronary syndromes: a population-based analysis of 83,357 patients

Doctor J. Comin-Colet (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Geographic variation in heart failure infrastructure capacity and cardiovascular disease burden in europe: a cross-sectional analysis

Mr S. Pradeep Kundur (London, GB)

Abstract Slides Video

Presentation thumbnail

Gender has impact on survival in post-capillary pulmonary hypertension due to heart failure: insights from the prospective and multicentre PH-HF study

Doctor C. Fauvel (Rouen, FR)

Abstract Slides Video

Access the full session

Session thumbnail

Prognostic modifiers in heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Presentation

Longitudinal trajectories in clinical status and cardiac remodeling across the heart failure spectrum: 12-month evidence from the BRING-UP-3 HF Study

Congress Session

Advances in heart failure detection and therapy

Congress Presentation

Discharge medical treatment implementation in patients admitted for AHF: preliminary data from the BRING-UP3 HF study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources